Correlation Engine 2.0
Clear Search sequence regions


  • brain (1)
  • brain neoplasms (1)
  • cancers (2)
  • factor (3)
  • female (1)
  • glioblastoma (4)
  • glioma (2)
  • GSCs (3)
  • HDAC1 (8)
  • HDAC1 protein (1)
  • heterografts (1)
  • human (2)
  • mice (1)
  • mice nude (1)
  • NF- κB (2)
  • NFAT2 (14)
  • NFATC (2)
  • nfatc1 protein (1)
  • nfatc1 protein, human (1)
  • prognostic (1)
  • protein human (1)
  • regulates (1)
  • signal (1)
  • stem cell (4)
  • t cell (1)
  • Sizes of these terms reflect their relevance to your search.

    Deregulation of the nuclear factor of activated T cell (NFAT) pathway has been reported in several human cancers. Particularly, NFAT2 is involved in the malignant transformation of tumor cells and is identified as an oncogene. However, the role of NFAT2 in glioblastoma (GBM) is largely unknown. The expression and prognostic value of NFAT2 were examined in the databases of the Repository of Molecular Brain Neoplasia Data and The Cancer Genome Atlas (TCGA) and clinical samples. The functional effects of silencing or overexpression of NFAT2 were evaluated in glioma stem cell (GSC) viability, invasion, and self-renewal in vitro and in tumorigenicity in vivo. The downstream target of NFAT2 was investigated. High NFAT2 expression was significantly associated with mesenchymal (MES) subtype and recurrent GBM and predicted poor survival. NFAT2 silencing inhibited the invasion and clonogenicity of MES GSC-enriched spheres in vitro and in vivo. NFAT2 overexpression promoted tumor growth and MES differentiation of GSCs. A TCGA database search showed that histone deacetylase 1 (HDAC1) expression was significantly correlated with that of NFAT2. NFAT2 regulates the transcriptional activity of HDAC1. Rescue of HDAC1 in NFAT2-knockdown GSCs partially restored tumor growth and MES phenotype. Loss of NFAT2 and HDAC1 expression resulted in hyperacetylation of nuclear factor-kappaB (NF-κB), which inhibits NF-κB-dependent transcriptional activity. Our findings suggest that the NFAT2-HDAC1 pathway might play an important role in the maintenance of the malignant phenotype and promote MES transition in GSCs, which provide potential molecular targets for the treatment of GBMs. © The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

    Citation

    Yifu Song, Yang Jiang, Dongxia Tao, Zixun Wang, Run Wang, Minghao Wang, Sheng Han. NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma. Neuro-oncology. 2020 Jan 11;22(1):46-57

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 31400279

    View Full Text